Skip to content
PubMed This is a summary of 70 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 70 referenced papers

Top Authors

Mark D. Fleming
Boston Children's Hospital
Caroline Kannengiesser
Centre National de la Recherche Scientifique
Dean R. Campagna
Boston Children's Hospital
Majid Alfadhel
King Saud bin Abdulaziz University for Health Sciences
Lemuel J. Pelentsov
University of South Australia

Top Institutions

Ranked by publications Top 10 institutions
02

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing, China

12 papers
06

Assistance Publique – Hôpitaux de Paris

Paris, France

7 papers
07

Centre Hospitalier Régional et Universitaire de Nancy

Nancy, France

3 papers
08

Hôpital Robert-Debré

Paris, France

3 papers

References

References (70)
  1. 1

    The 3' addition of CCA to mitochondrial tRNASer(AGY) is specifically impaired in patients with mutations in the tRNA nucleotidyl transferase TRNT1.

    Sasarman F, Thiffault I, Weraarpachai W, et al.

    Human molecular genetics 2015; (24(10)):2841-7 doi:10.1093/hmg/ddv044.

    PMID: 25652405
  2. 2

    The supportive care needs of parents caring for a child with a rare disease: A scoping review.

    Pelentsov LJ, Laws TA, Esterman AJ

    Disability and health journal 2015; (8(4)):475-91.

    PMID: 25959710
  3. 3

    Functional Analysis of GLRX5 Mutants Reveals Distinct Functionalities of GLRX5 Protein.

    Liu G, Wang Y, Anderson GJ, et al.

    Journal of cellular biochemistry 2016; (117(1)):207-17 doi:10.1002/jcb.25267.

    PMID: 26100117
  4. 4

    Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.

    Schmitz-Abe K, Ciesielski SJ, Schmidt PJ, et al.

    Blood 2015; (126(25)):2734-8 doi:10.1182/blood-2015-09-659854.

    PMID: 26491070
  5. 5

    Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.

    Cazzola M, Malcovati L

    Hematology. American Society of Hematology. Education Program 2015; (2015()):19-25 doi:10.1182/asheducation-2015.1.19.

    PMID: 26637696
  6. 6

    Expanding the Phenotype of TRNT1-Related Immunodeficiency to Include Childhood Cataract and Inner Retinal Dysfunction.

    Hull S, Malik AN, Arno G, et al.

    JAMA ophthalmology 2016; (134(9)):1049-53 doi:10.1001/jamaophthalmol.2015.5833.

    PMID: 27389523
  7. 7

    The supportive care needs of parents with a child with a rare disease: results of an online survey.

    Pelentsov LJ, Fielder AL, Laws TA, Esterman AJ

    BMC family practice 2016; (17()):88 doi:10.1186/s12875-016-0488-x.

    PMID: 27439905
  8. 8

    Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia.

    Lunetti P, Damiano F, De Benedetto G, et al.

    The Journal of biological chemistry 2016; (291(38)):19746-59 doi:10.1074/jbc.M116.736876.

    PMID: 27476175
  9. 9

    Perceived Benefits and Factors that Influence the Ability to Establish and Maintain Patient Support Groups in Rare Diseases: A Scoping Review.

    Delisle VC, Gumuchian ST, Rice DB, et al.

    The patient 2017; (10(3)):283-293 doi:10.1007/s40271-016-0213-9.

    PMID: 28004275
  10. 10

    Mitochondrial iron-sulfur cluster biogenesis from molecular understanding to clinical disease.

    Alfadhel M, Nashabat M, Abu Ali Q, Hundallah K

    Neurosciences (Riyadh, Saudi Arabia) 2017; (22(1)):4-13 doi:10.17712/nsj.2017.1.20160542.

    PMID: 28064324
  11. 11

    Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.

    Kirk P, Sheppard M, Carpenter JP, et al.

    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2017; (19(1)):36 doi:10.1186/s12968-017-0349-3.

    PMID: 28343449
  12. 12

    Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.

    Zurynski Y, Deverell M, Dalkeith T, et al.

    Orphanet journal of rare diseases 2017; (12(1)):68 doi:10.1186/s13023-017-0622-4.

    PMID: 28399928
  13. 13

    The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes.

    Monies D, Abouelhoda M, AlSayed M, et al.

    Human genetics 2017; (136(8)):921-939 doi:10.1007/s00439-017-1821-8.

    PMID: 28600779
  14. 14

    Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.

    Le Rouzic MA, Fouquet C, Leblanc T, et al.

    Blood cells, molecules & diseases 2017; (66()):11-18 doi:10.1016/j.bcmd.2017.07.003.

    PMID: 28772256
  15. 15

    SIFD as a novel cause of severe fetal hydrops and neonatal anaemia with iron loading and marked extramedullary haemopoiesis.

    Barton C, Kausar S, Kerr D, et al.

    Journal of clinical pathology 2018; (71(3)):275-278 doi:10.1136/jclinpath-2017-204698.

    PMID: 29055896
  16. 16

    Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors.

    Giannelou A, Wang H, Zhou Q, et al.

    Annals of the rheumatic diseases 2018; (77(4)):612-619 doi:10.1136/annrheumdis-2017-212401.

    PMID: 29358286
  17. 17

    Novel mutations in mitochondrial carrier family gene SLC25A38, causing congenital sideroblastic anemia in Iranian families, identified by whole exome sequencing.

    Mehri M, Zarin M, Ardalani F, et al.

    Blood cells, molecules & diseases 2018; (71()):39-44 doi:10.1016/j.bcmd.2018.02.002.

    PMID: 29499877
  18. 18

    Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias.

    Shefer Averbuch N, Steinberg-Shemer O, Dgany O, et al.

    European journal of haematology 2018; (101(3)):297-304 doi:10.1111/ejh.13097.

    PMID: 29786897
  19. 19

    Congenital sideroblastic anemia: Advances in gene mutations and pathophysiology.

    Long Z, Li H, Du Y, Han B

    Gene 2018; (668()):182-189 doi:10.1016/j.gene.2018.05.074.

    PMID: 29787825
  20. 20

    Rare anemias due to genetic iron metabolism defects.

    Brissot P, Bernard DG, Brissot E, et al.

    Mutation research. Reviews in mutation research 2018; (777()):52-63 doi:10.1016/j.mrrev.2018.06.003.

    PMID: 30115430
  21. 21

    Alone in a Crowd? Parents of Children with Rare Diseases' Experiences of Navigating the Healthcare System.

    Baumbusch J, Mayer S, Sloan-Yip I

    Journal of genetic counseling 2018; doi:10.1007/s10897-018-0294-9.

    PMID: 30128673
  22. 22

    Pathophysiology and classification of iron overload diseases; update 2018.

    Brissot P, Troadec MB, Loréal O, Brissot E

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2019; (26(1)):80-88 doi:10.1016/j.tracli.2018.08.006.

    PMID: 30173950
  23. 23

    GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.

    Daher R, Mansouri A, Martelli A, et al.

    Molecular genetics and metabolism 2019; (128(3)):342-351 doi:10.1016/j.ymgme.2018.12.012.

    PMID: 30660387
  24. 24

    Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.

    Peoc'h K, Nicolas G, Schmitt C, et al.

    Molecular genetics and metabolism 2019; (128(3)):190-197 doi:10.1016/j.ymgme.2019.01.015.

    PMID: 30737140
  25. 25

    Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency.

    Kumaki E, Tanaka K, Imai K, et al.

    International journal of hematology 2019; (109(4)):382-389 doi:10.1007/s12185-019-02614-0.

    PMID: 30758723
  26. 26

    Graft failure after reduced-intensity stem cell transplantation for congenital sideroblastic anemia.

    Imataki O, Uchida S, Uemura M, Kadowaki N

    Pediatric hematology and oncology 2019; (36(1)):46-51 doi:10.1080/08880018.2019.1578844.

    PMID: 30912988
  27. 27

    Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.

    Fouquet C, Le Rouzic MA, Leblanc T, et al.

    British journal of haematology 2019; (187(4)):530-542 doi:10.1111/bjh.16100.

    PMID: 31338833
  28. 28

    Reticulocyte Hemoglobin Equivalent (Ret-He) Combined with Red Blood Cell Distribution Width Has a Differentially Diagnostic Value for Thalassemias.

    Lian Y, Shi J, Nie N, et al.

    Hemoglobin 2019; (43(4-5)):229-235 doi:10.1080/03630269.2019.1655440.

    PMID: 31476929
  29. 29

    [Clinical features and gene mutation spectrum in children with sideroblastic anemia].

    An WB, An WB, Liu C, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(10)):1016-1021.

    PMID: 31642437
  30. 30

    Novel biallelic TRNT1 mutations lead to atypical SIFD and multiple immune defects.

    Yang L, Xue X, Zeng T, et al.

    Genes & diseases 2020; (7(1)):128-137 doi:10.1016/j.gendis.2020.01.005.

    PMID: 32181284
  31. 31

    Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.

    Uminski K, Houston DS, Hartley JN, et al.

    Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.

    PMID: 32790119
  32. 32

    Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options.

    Abu-Zeinah G, DeSancho MT

    Journal of blood medicine 2020; (11()):305-318 doi:10.2147/JBM.S232644.

    PMID: 33061728
  33. 33

    A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels.

    Lira Zidanes A, Marchi G, Busti F, et al.

    Frontiers in physiology 2020; (11()):581386 doi:10.3389/fphys.2020.581386.

    PMID: 33281618
  34. 34

    SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature.

    Heeney MM, Berhe S, Campagna DR, et al.

    Human mutation 2021; (42(11)):1367-1383 doi:10.1002/humu.24267.

    PMID: 34298585
  35. 35

    A phenotypic expansion of TRNT1 associated sideroblastic anemia with immunodeficiency, fevers, and developmental delay.

    Odom J, Amin H, Gijavanekar C, et al.

    American journal of medical genetics. Part A 2022; (188(1)):259-268 doi:10.1002/ajmg.a.62482.

    PMID: 34510712
  36. 36

    COVID-19 associated respiratory failure complicating a pericardial effusion in a patient with sideroblastic anemia.

    Sayad E, Hammoud M, Khreis D, et al.

    Respiratory medicine case reports 2021; (34()):101543 doi:10.1016/j.rmcr.2021.101543.

    PMID: 34777989
  37. 37

    Common needs in uncommon conditions: a qualitative study to explore the need for care in pediatric patients with rare diseases.

    Smits RM, Vissers E, Te Pas R, et al.

    Orphanet journal of rare diseases 2022; (17(1)):153 doi:10.1186/s13023-022-02305-w.

    PMID: 35379257
  38. 38

    Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases.

    Bogart K, Hemmesch A, Barnes E, et al.

    Orphanet journal of rare diseases 2022; (17(1)):196 doi:10.1186/s13023-022-02343-4.

    PMID: 35549731
  39. 39

    The diagnostic odyssey: insights from parents of children living with an undiagnosed condition.

    Bauskis A, Strange C, Molster C, Fisher C

    Orphanet journal of rare diseases 2022; (17(1)):233 doi:10.1186/s13023-022-02358-x.

    PMID: 35717227
  40. 40

    When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms.

    Girard S, Genevieve F, Rault E, et al.

    Diagnostics (Basel, Switzerland) 2022; (12(7)) doi:10.3390/diagnostics12071752.

    PMID: 35885655
  41. 41

    Quality of life of Brazilian families who have children with Rubinstein-Taybi syndrome: An exploratory cross-sectional study.

    Vale AR, de Avó LRDS, Pilotto RF, et al.

    American journal of medical genetics. Part A 2022; (188(11)):3294-3305 doi:10.1002/ajmg.a.62914.

    PMID: 35913016
  42. 42

    Clinical and Therapeutic Aspects of Sideroblastic Anaemia with B-Cell Immunodeficiency, Periodic Fever and Developmental Delay (SIFD) Syndrome: a Systematic Review.

    Maccora I, Ramanan AV, Wiseman D, et al.

    Journal of clinical immunology 2023; (43(1)):1-30 doi:10.1007/s10875-022-01343-0.

    PMID: 35984545
  43. 43

    A Rare Autoinflammatory Disorder in a Pediatric Patient with Favorable Response to Etanercept: Sideroblastic Anemia with B Cell Immunodeficiency, Periodic Fevers, and Developmental Delay Syndrome.

    Kisla Ekinci RM, Zararsiz A, Demir GU, Anlas O

    Pediatric allergy, immunology, and pulmonology 2022; (35(3)):129-132 doi:10.1089/ped.2022.0090.

    PMID: 36121781
  44. 44

    Causes and Pathophysiology of Acquired Sideroblastic Anemia.

    Rodriguez-Sevilla JJ, Calvo X, Arenillas L

    Genes 2022; (13(9)) doi:10.3390/genes13091562.

    PMID: 36140729
  45. 45

    Iron Metabolism in the Disorders of Heme Biosynthesis.

    Ricci A, Di Betto G, Bergamini E, et al.

    Metabolites 2022; (12(9)) doi:10.3390/metabo12090819.

    PMID: 36144223
  46. 46

    Children with a rare congenital genetic disorder: a systematic review of parent experiences.

    von der Lippe C, Neteland I, Feragen KB

    Orphanet journal of rare diseases 2022; (17(1)):375 doi:10.1186/s13023-022-02525-0.

    PMID: 36253830
  47. 47

    Thalidomide as an Effective Treatment in Sideroblastic Anemia, Immunodeficiency, Periodic Fevers, and Developmental Delay (SIFD).

    Li Y, Deng M, Han T, et al.

    Journal of clinical immunology 2023; (43(4)):780-793 doi:10.1007/s10875-023-01441-7.

    PMID: 36729249
  48. 48

    Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience.

    Shamsian BS, Jafari MR, Abolghasemi H, et al.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2023; (21(1)):70-75 doi:10.6002/ect.2022.0081.

    PMID: 36757170
  49. 49

    Three siblings with variable degrees of neuromuscular involvement and congenital sideroblastic anemia: A peculiar phenotype and a surprise genotypic explanation.

    Salam MAE, Salama K, Selim YMM, et al.

    Annals of human genetics 2023; (87(4)):166-173 doi:10.1111/ahg.12505.

    PMID: 36916508
  50. 50

    [Measures for optimal access to psychosocial care of children with rare diseases and their families].

    Witt S, Kristensen K, Wiegand-Grefe S, Quitmann J

    Innere Medizin (Heidelberg, Germany) 2023; (64(5)):494-499 doi:10.1007/s00108-023-01496-z.

    PMID: 36988654
  51. 51

    How parents of children with ataxia-telangiectasia use dynamic coping to navigate cyclical uncertainty.

    Schiller J, Towne MC, Epstein R, et al.

    Journal of genetic counseling 2024; (33(2)):301-313 doi:10.1002/jgc4.1727.

    PMID: 37183503
  52. 52

    Comprehensive Genomic Analysis Identifies a Diverse Landscape of Sideroblastic and Nonsideroblastic Iron-Related Anemias with Novel and Pathogenic Variants in an Iron-Deficient Endemic Setting.

    Sharma P, Bhatia P, Singh M, et al.

    The Journal of molecular diagnostics : JMD 2024; (26(5)):430-444 doi:10.1016/j.jmoldx.2024.01.011.

    PMID: 38360212
  53. 53

    Zinc-Containing Over-The-Counter Product Causing Sideroblastic Anemia and Neutropenia.

    Stagg MP, Miatech J, Majid B, Polala R

    Cureus 2024; (16(5)):e59796 doi:10.7759/cureus.59796.

    PMID: 38846187
  54. 54

    Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients.

    Dongerdiye R, Kedar PS, Saptarshi A, et al.

    Annals of hematology 2024; (103(10)):3987-3998 doi:10.1007/s00277-024-05969-5.

    PMID: 39196378
  55. 55

    A novel and apparent de novo ALAS2 missense variant associated with congenital sideroblastic anemia.

    Cai J, Liu T, Huang Y, et al.

    Frontiers in pediatrics 2024; (12()):1411676 doi:10.3389/fped.2024.1411676.

    PMID: 39281190
  56. 56

    Improving Social Media-Based Support Groups for the Rare Disease Community: Interview Study With Patients and Parents of Children with Rare and Undiagnosed Diseases.

    Doyle TA, Vershaw SL, Conboy E, Halverson CME

    JMIR human factors 2024; (11()):e57833 doi:10.2196/57833.

    PMID: 39752188
  57. 57

    Case report: A novel 11-bp deletion in exon 11 causing a frameshift in the C-terminal of the ALAS2 gene leading to X-linked sideroblastic anemia-a family study.

    Al Kindi S, Al-Mamari A, Al-Zadjali S, et al.

    Frontiers in medicine 2024; (11()):1452873 doi:10.3389/fmed.2024.1452873.

    PMID: 39995829
  58. 58

    Sideroblastic anemia in children: challenges in diagnosis and management in three cases.

    Rekaya S, Ben Fraj I, Hamdi R, et al.

    Annals of hematology 2025; (104(4)):2537-2543 doi:10.1007/s00277-025-06266-5.

    PMID: 40042629
  59. 59

    The role of genetic testing in accurate diagnosis of X-linked sideroblastic anemia: novel ALAS2 mutations and the impact of X-chromosome inactivation.

    Jové-Solavera D, Rámila M, Ferrer-Cortés X, et al.

    Scientific reports 2025; (15(1)):11843 doi:10.1038/s41598-025-95590-x.

    PMID: 40195342
  60. 60

    A Rare Cause of Primary Microcephaly: 4 New Variants in CDK5RAP2 Gene and Review of the Literature.

    Erdogan M, Unal A, Dogan ME, et al.

    American journal of medical genetics. Part A 2025; (197(9)):e64072 doi:10.1002/ajmg.a.64072.

    PMID: 40243280
  61. 61

    Infant With a Severe Form of GLRX5-Related Atypical Hyperglycinemia Exhibiting Novel Cardiac and Neurologic Disease Manifestations at Autopsy.

    Ferreira EO, Del Bigio MR, Morin J, Frosk P

    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2025; (28(5)):390-394 doi:10.1177/10935266251335065.

    PMID: 40415601
  62. 62

    Vitamin B6 Deficiency May Not Always Present As Microcytic Hypochromic Anemia.

    Nakao S, Nakaseko C, Ishii T, et al.

    Cureus 2025; (17(6)):e86768 doi:10.7759/cureus.86768.

    PMID: 40718336
  63. 63

    Autosomal recessive frameshift variant broadens HECW2-related disease spectrum.

    Dehghanzad R, Eshaghkhani Y, Saberi M, et al.

    European journal of medical genetics 2025; (77()):105036 doi:10.1016/j.ejmg.2025.105036.

    PMID: 40812465
  64. 64

    [The 511th case: severe anemia with increased ringed sideroblasts].

    Liu ZW, Chen M, Han B

    Zhonghua nei ke za zhi 2025; (64(9)):906-910 doi:10.3760/cma.j.cn112138-20250616-00348.

    PMID: 40904303
  65. 65

    "I don't grieve as much as I used to": A qualitative study on parents of children with rare and undiagnosed conditions navigating grief in the context of uncertainty.

    Hoffmann TM, Friedrich B, Lewis C

    Journal of genetic counseling 2025; (34(6)):e70149 doi:10.1002/jgc4.70149.

    PMID: 41317142
  66. 66

    Rare and resilient: Longer-term experiences of families after genetic evaluation in the neonatal intensive care unit.

    Abouhala S, Del Rosario MC, Holm IA, Wojcik MH

    Genetics in medicine open 2026; (4()):103490 doi:10.1016/j.gimo.2025.103490.

    PMID: 41657716
  67. 67

    Prognostic Factors for Sideroblastic Anemia with B-cell Immunodeficiency, Periodic Fevers, and Developmental Delay Due to TRNT1 Gene Mutations: A Case Report and Systematic Review.

    Su TH, Lee NC, Wang LC, et al.

    Journal of clinical immunology 2026; (46(1)).

    PMID: 41795040
  68. 68

    A case report of congenital sideroblastic anemia caused by a novel ALAS2 mutation in conjunction with thalassemia.

    Chen ZX, Yang LY, Wang LT, et al.

    Annals of hematology 2026; (105(5)).

    PMID: 41961321
  69. 69

    A diagnostic pitfall in iron-refractory microcytic hypochromic anemia with acquired ring sideroblasts initially treated as iron deficiency anemia-a case report.

    Liu X, Ma J, Song A, et al.

    Frontiers in medicine 2026; (13()):1838995 doi:10.3389/fmed.2026.1838995.

    PMID: 42338942
  70. 70

    Expanding the spectrum of Sideroblastic Anemia with B-cell Immunodeficiency, Periodic Fever and Developmental Delay (SIFD) syndrome: a case report with new clinical insights and novel genetic variant.

    Delle Cave F, Taietti I, Agostini A, et al.

    Frontiers in immunology 2026; (17()):1876025 doi:10.3389/fimmu.2026.1876025.

    PMID: 42688123